OrthoLazer providers are changing the way orthopedic medicine is practiced. Trochanteric Bursitis is a chronic condition affecting millions each year. A challenging diagnosis, it is often refractory to physical therapy and trochanteric bursal Cortisone injections. In addition, the risk of tendon tears in the gluteus medius/minimus sometimes outweighs the benefits of repeated steroid injections. Laser therapy has proven to be an excellent alternative for patients looking for a non-invasive and regenerative solution while avoiding the risks of steroids. Dr. Asheesh Gupta, founder of OrthoLazer Woodbridge, has developed a laser therapy protocol to address this challenging problem and his patients are experiencing significant relief. Dr. Gupta shares “Trochanteric Bursitis is a condition I see often in my practice. My treatment goal is to help control pain and inflammation while keeping my patients mobile. I am finding success with the combination of one Cortisone injection followed by 12 laser therapy sessions and sometimes physical therapy to address involved structures, including ITB stretching and dry needling. I also recommend Laser Maintenance Therapy as important for avoiding future flare-ups.” Remember! Your endorsement helps your patients access the clinical benefits of laser therapy. Patient education materials can be helpful in your practice’s workflow. All previous Clinical News editions are archived in the OrthoLazer Knowledge Center.
|
Lisa Moore, MSPT Director, Provider Engagement OrthoLazer Orthopedic Laser |
